4/A//SEC Filing
Chan Heng Fai Ambrose 4/A
Accession 0001641172-25-026290
CIK 0000771999other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 9:30 PM ET
Size
9.8 KB
Accession
0001641172-25-026290
Insider Transaction Report
Form 4/AAmended
DSS, INC.DSS
CHAN FAI
Director10% Owner
Transactions
- Other
Convertible Promissory Note
2025-08-20(indirect: See footnote)From: 2025-08-20Exp: 2028-07-31→ Common Stock
Alset Inc.
10% Owner
Transactions
- Other
Convertible Promissory Note
2025-08-20(indirect: See footnote)From: 2025-08-20Exp: 2028-07-31→ Common Stock
Footnotes (3)
- [F1]This Amended Form 4 is being filed to clarify certain information set forth on the Form 4 originally filed by the reporting persons on August 22, 2025.
- [F2]On August 20, 2025, the Issuer issued a convertible promissory note (the "Convertible Promissory Note") to Alset Inc. in the amount of $500,000. Under the terms of the Convertible Promissory Note, Alset Inc. may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of either (i) $0.86 per share, or (ii) if while the Convertible Promissory Note is outstanding, the Issuer sells or issues any other convertible instruments on terms that differ from the Convertible Promissory Note, the Holder may elect to exchange the Convertible Promissory Note for such convertible instrument based on the Convertible Promissory Note's principal balance plus any accrued but unpaid interest.
- [F3]The beneficial ownership of Mr. Chan as of August 22, 2025 may be deemed to include the following (a) 1,002,978 shares of the Issuer's common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 1,184,475 shares of the Issuer's common stock held by Mr. Chan directly; (c) 2,581,268 shares of the Issuer's common stock held by Alset Inc., an entity controlled by Mr. Chan; (d) a convertible promissory note in the amount of $500,000 held by Alset Inc. and convertible into shares of the Issuer's common stock; (e) 1,068,309 shares of the Issuer's common stock held by Alset International Limited, an entity controlled by Mr. Chan and a subsidiary of Alset Inc.; and (f) 311,634 shares of the Issuer's common stock held by Global Biomedical Pte. Ltd., an entity controlled by Mr. Chan and a subsidiary of Alset International Limited (which is a subsidiary of Alset Inc.).
Documents
Issuer
DSS, INC.
CIK 0000771999
Entity typeother
Related Parties
1- filerCIK 0001261725
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 9:30 PM ET
- Size
- 9.8 KB